Advanced Bone Health Services Inc.(ABHS) utilizes REMS (Radiofrequency Echographic Multi-Spectrometry) technology, a Health Canada-approved European innovation that redefines bone health assessment. Unlike traditional DEXA imaging, the REMS system analyzes raw, backscattered ultrasound signals to evaluate both the quantity (BMD) and the micro-architectural quality of bone. This dual analysis generates a validated Fragility Score—a 5-year probability of major osteoporotic fracture that is independent of BMD. Furthermore, REMS is natively resistant to the artifacts that often compromise DEXA results, such as osteoarthritis, scoliosis, or calcifications.
The public health burden of osteoporosis—a “silent” chronic disease that remains largely undiagnosed in millions of Canadians until a debilitating first fracture occurs. Current diagnostic access is often hindered by hospital wait times and provincial guidelines that frequently delay baseline DEXA screening until age 65.
Advanced Bone Health Services (ABHS) addresses these gaps by offering the first commercial mobile ultrasound for measurement of bone mineral density (BMD) in Canada, providing clinicians with a portable and radiation-free alternative for population-level screening and fracture prevention. Our service is offered by international medical graduates experienced and licensed in diagnostic ultrasound applications.
By incorporating ABHS into your patient’s care plan, you gain access to a radiation-free diagnostic that is ideal for serial monitoring and proactive screening in high-risk populations, including those under 65. Our service is mobile, bringing hospital-grade diagnostics directly to community clinics and senior centers. Our state-of the art system provides immediate, easy-to-read medical reports—including T-scores and Z-scores— allowing for timely therapeutic interventions and personalized preventative strategies.